In our analysis of MTAP deficient NSCLC subjects, while the overall KRAS or STK11 genomic alterations did not show any significant difference, KRAS G12C mutations were lower in MTAP‐loss versus MTAP‐intact tumors. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.